Search

Your search keyword '"Morimoto, Takashi"' showing total 867 results
Start Over Author "Morimoto, Takashi"
867 results on '"Morimoto, Takashi"'

18. Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)

Author

Aogi, Kenjiro, Watanabe, Kenichi, Kitada, Masahiro, Sangai, Takafumi, Ohtani, Shoichiro, Aruga, Tomoyuki, Kawaguchi, Hidetoshi, Fujisawa, Tomomi, Maeda, Shigeto, Morimoto, Takashi, Sato, Nobuaki, Takao, Shintaro, Morita, Satoshi, Masuda, Norikazu, Toi, Masakazu, and Ohno, Shinji

Published
2022
Full Text
View/download PDF

22. A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer

Author

Ishiguro, Hiroshi, Masuda, Norikazu, Sato, Nobuaki, Higaki, Kenji, Morimoto, Takashi, Yanagita, Yasuhiro, Mizutani, Makiko, Ohtani, Shoichiro, Kaneko, Koji, Fujisawa, Tomomi, Takahashi, Masato, Kadoya, Takayuki, Matsunami, Nobuki, Yamamoto, Yutaka, Ohno, Shinji, Takano, Toshimi, Morita, Satoshi, Tanaka-Mizuno, Sachiko, and Toi, Masakazu

Published
2020
Full Text
View/download PDF

30. De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer

Author

Tanaka, Satoru, Matsunami, Nobuki, Morishima, Hirotaka, Oda, Naofumi, Takashima, Tsutomu, Noda, Satoru, Kashiwagi, Shinichiro, Tauchi, Yukie, Asano, Yuka, Kimura, Kosei, Fujioka, Hiroya, Terasawa, Risa, Kawaguchi, Kanako, Ikari, Ayana, Morimoto, Takashi, Michishita, Shintaro, Kobayashi, Toshihiro, Sakane, Junna, Nitta, Toshikatsu, Sato, Nayuko, Hokimoto, Norihiro, Nishida, Yukihiro, and Iwamoto, Mitsuhiko

Published
2019
Full Text
View/download PDF

32. Practical Solutions for Addressing Challenges in National Reporting for the Enhanced Transparency Framework: Cases from Developing Countries in the Asia–Pacific Region.

Author

Murun, Temuulen, Umemiya, Chisa, Morimoto, Takashi, and Hattori, Tomohiko

Abstract

Transitioning to the Enhanced Transparency Framework (ETF) under the Paris Agreement (PA) from the current measurement, reporting and verification (MRV) arrangements under the United Nations Framework Convention on Climate Change (UNFCCC) requires developing countries to enhance their national reporting systems in a sustainable way. There are various challenges that developing countries face in preparing national reporting under the existing MRV framework. The objective of this paper is to identify practical solutions as good practices in the short and long term to address the common challenges facing many developing countries as they prepare their national climate reporting. We collected information on practical solutions implemented by developing countries to overcome common challenges during preparation of their national reporting. There were some limitations regarding data collection using a country survey since we received responses from only six countries and two organizations, resulting in a small sample. Good practices for addressing common challenges include developing a national legal framework for transparency-related work, assigning a main coordinating institution, collaborating with domestic institutions for methodology development on emission reduction, and establishing university curricula on transparency. Replicating these solutions as good practices on how to deal with the challenges would be one way for developing countries to enhance their respective reporting systems in a sustainable manner. Furthermore, the paper highlights three underlying factors (efficiency, accountability, and sustainability) behind those practical solutions. These underlying factors should be considered important as guiding principles for building sustainable reporting systems in order to be able to successfully implement the ETF. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

38. A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: evaluation of efficacy, safety, and patient-reported outcomes

Author

Kimura, Kosei, Iwamoto, Mitsuhiko, Tanaka, Satoru, Yamamoto, Daigo, Yoshidome, Katsuhide, Ogura, Hiroyuki, Terasawa, Risa, Matsunami, Nobuki, Takahashi, Yuko, Nitta, Toshikatsu, Morimoto, Takashi, Fujioka, Hiroya, Kawaguchi, Kanako, and Uchiyama, Kazuhisa

Published
2018
Full Text
View/download PDF

50. Report on the individual review of the annual submission of the Netherlands submitted in 2021

Author

Sturgiss, Robert, Yang, Hongwei, Morimoto, Takashi, Mukhigulishvili, Giorgi, Hunstone , Mark Edward, Nielsen, Ole-Kenneth, Gibbs, Joel, Kouazounde, Jacques, Sato, Atsushi, Yanagawa, Midori, Jakarasi, Veronica, and Towprayoon, Sirintornthep

Abstract

This report covers the review of the 2021 annual submission of the Netherlands, organized by the secretariat in accordance with the Article 8 review guidelines (adopted by decision 22/CMP.1 and revised by decision 4/CMP.11). In accordance with the Article 8 review guidelines, this review process also encompasses the review under the Convention as described in the UNFCCC review guidelines, particularly in part III thereof, namely the “UNFCCC guidelines for the technical review of greenhouse gas inventories from Parties included in Annex I to the Convention” (annex to decision 13/CP.20).

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results